Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rhythm Pharmaceuticals buy Morgan Stanley

Start price
€74.50
11.07.25 / 50%
Target price
€81.37
11.07.26
Performance (%)
13.42%
Price
?
07:33
Summary
This prediction is currently active. The prediction currently has a performance of 13.42%. This prediction currently runs until 11.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Rhythm Pharmaceuticals 6.000% 6.000%
iShares Core DAX® 1.061% -0.453%
iShares Nasdaq 100 2.615% 4.747%
iShares Nikkei 225® 5.693% 9.002%
iShares S&P 500 1.433% 3.156%

Comments by Morgan_Stanley for this prediction

In the thread Rhythm Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 13.42%
Target price 81.368
Change
Ends at 11.07.26

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was given a new $95.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat

Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€46.80
07.03.25
€66.38
07.03.26
80.56%
07:33

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€42.40
19.12.23
€50.16
19.12.24
30.90%
20.12.24